NautaDutilh advised Vivoryon Therapeutics in its private placement. Vivoryon Therapeutics, a clinical-stage company committed to discovering and developing small molecule medicines to regulate the activity and...
Vivoryon Therapeutics’ EUR25 Million Private Placement
Vivoryon Therapeutics’ Strategic Regional Licensing Partnership with Simcere Pharmaceutical Group Ltd.
Freshfields Bruckhaus Deringer advised Vivoryon Therapeutics N.V. Vivoryon Therapeutics N.V., a clinical-stage biotechnology company focused on developing innovative small molecule-based medicines, signed a strategic regional licensing...